FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of October 31, 2014. No amounts were accrued for the payment of interest and penalties at October 31, 2014. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
The Company may be subject to potential examination by U.S. federal, U.S. state, U.S. city or foreign jurisdiction authorities in the areas of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with U.S. federal, U.S. state, U.S. city and foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
The Company’s policy for recording interest and penalties associated with audit is to record such expense as a component of income tax expense. Management is currently unaware of any issues under review that could result in significant payments, accruals, or material deviations from its position.
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date of the financial statements are filed with the SEC for potential recognition or disclosure. Any material events that occur between the balance sheet date and filing date are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that exist at the balance sheet date.
Pursuant to the Proposed Offering, the Company will offer for sale 10,000,000 units, and an additional 1,500,000 units issuable if the underwriters for the Proposed Offering exercise their overallotment option in full, at $10.00 per unit (“Units”). The underwriters will have 45 days following the closing of the Proposed Offering to exercise their overallotment option. Each Unit will consist of one share of the Company’s common stock, $0.001 par value, and one redeemable common stock purchase warrant. The Company is not at this time registering under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock issuable upon exercise of the warrants. However, the Company has agreed to use its best efforts to file and have an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the warrants, to maintain a current prospectus relating to those shares of common stock until the earlier of the date the warrants expire or are redeemed and the date on which all of the warrants have been exercised, and to qualify the resale of such shares under state blue sky laws, to the extent an exemption is not available. Each warrant will entitle the holder to purchase one share of common stock at an exercise price of $12.00 and will become exercisable on the later of (a) 30 days after the consummation of the initial Business Combination, or (b) 12 months from the closing of the Proposed Offering. The warrants will expire at 5:00 p.m., New York time, five years after the consummation of the initial Business Combination or earlier upon redemption or liquidation. On the exercise of any warrant, the warrant exercise price will be paid directly to the Company and not placed in the Trust Account. The warrants will be redeemable by the Company at a price of $0.01 per warrant upon 30 days prior written notice after the warrants become exercisable, only in the event that the last sale price of the common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third business day prior to the date on which notice of redemption is given. The Company will not redeem the warrants unless an effective registration statement covering the shares of common stock issuable upon exercise of the warrants is current and available throughout the 30-day redemption period. If the Company does not complete a Business Combination, then the warrants will expire worthless. The Company intends to classify the warrants within permanent equity as additional paid-in capital in accordance with ASC 815-40 “Derivatives and Hedging.”
Table of Contents
In connection with the Proposed Offering, the Sponsor and Cantor Fitzgerald have committed to purchase 300,000 placement units (200,000 placement units by the Sponsor and 100,000 placement units by Cantor Fitzgerald) (the “placement units”), each consisting of one share of common stock and one warrant (each, a “placement warrant”) to purchase one share of our common stock exercisable at $12.00, at a price of $10.00 per unit in a private placement that will occur simultaneously with the consummation of the Proposed Offering. The total purchase price for the placement units will be $3.0 million. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the placement shares or warrants.
The placement units and their component securities are the same as the public units and their component securities except that they may not be transferable, assignable or salable until 30 days after the consummation of the initial Business Combination, subject to certain limited exceptions, and the placement warrants will be non-redeemable and may be exercised on a cashless basis so long as they are held by the Sponsor, Cantor Fitzgerald, or their permitted transferees. If the placement warrants are held by someone other than the Sponsor, Cantor Fitzgerald, or their permitted transferees, the placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units. In addition, for as long as the placement warrants are held by Cantor Fitzgerald or its designees or affiliates, they may not be exercised after five years from the effective date of the registration statement of which this prospectus forms a part.
4. RELATED PARTY TRANSACTIONS
In order to finance organizational costs and other costs relating to the Proposed Offering, the Sponsor has committed to loan the Company funds as may be required, to a maximum of $500,000. These loans will be non-interest bearing, unsecured and payable on the earlier of March 31, 2015 or the consummation of the Proposed Offering. On May 1, 2014, the Sponsor paid $7,544 for organizational costs on behalf of the Company. On September 16, 2014, the Sponsor paid $17,750 for costs related to the Proposed Offering on behalf of the Company. At October 31, 2014, the balance outstanding was $25,294.
In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor has committed to loan the Company funds as may be required, to a maximum of $750,000. If the Company consummates an initial Business Combination, the Company will repay such loaned amounts. If the Company does not consummate an initial Business Combination, the Company may use a portion of any working capital held outside the Trust Account to repay such loaned amounts; however, no proceeds from the Trust Account may be used for such repayment, other than interest income earned thereon. If such funds are insufficient to repay the full amount loaned, the unpaid amounts would be forgiven. Any part or all of such loans may be convertible into additional warrants at $0.75 per warrant (a maximum of 1,000,000 warrants if the full $750,000 is loaned and that amount is converted into warrants) of the post-business combination entity at the option of the lender. The warrants would be identical to the placement warrants.
On November 1, 2013, the Company issued an aggregate of 112 shares of common stock to certain of the Initial Shareholders for an aggregate purchase price of $112, and on July 2, 2014, the Company issued an aggregate of 3,916,555 shares of common stock to certain of the Initial Shareholders for an aggregate purchase price of $24,888 (these shares, together with the 16,666 shares of common stock issued on January 12, 2015, are referred to as the “Founder Shares”). If the Company increases the size of the Proposed Offering, the number of Founder Shares may be increased through a stock dividend in order to maintain the ownership represented by the Founder Shares at the same percentage as was the case before the stock dividend. If the underwriters do not exercise all or a portion of their overallotment option, the Initial Shareholders have agreed, pursuant to a written agreement with the Company, that they will forfeit up to an aggregate of 500,000 Founder Shares in proportion to the portion of the underwriters’ overallotment option that was not exercised.
The Founder Shares are identical to the shares of common stock included in the Units being sold in the Proposed Offering, except that (1) the Founder Shares are subject to certain transfer restrictions, as described in more detail below, and (2) the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares (i) in connection with the consummation of a Business Combination, (ii) if the Company fails to consummate a Business Combination within 18 months from the consummation of the Proposed Offering and (iii) upon the Company’s liquidation prior to the expiration of the 18 month period. If
F-11
Table of Contents
the Company submits the initial Business Combination to the Company’s public shareholders for a vote, the Initial Shareholders have agreed to vote their Founder Shares, any public shares they hold, and in the case of the Sponsor, its placement shares, in favor of the initial Business Combination.
The Initial Shareholders have agreed not to transfer, assign or sell any of their Founder Shares (except to permitted transferees) until (i) with respect to 20% of such shares, upon consummation of the Company’s initial Business Combination, (ii) with respect to 20% of such shares, when the closing price of the Company’s common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 20% of such shares, when the closing price of the Company’s common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iv) with respect to 20% of such shares, when the closing price of the Company’s common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination and (v) with respect to 20% of such shares, when the closing price of the Company’s common stock exceeds $17.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination or earlier, in any case, if, following a Business Combination, the Company engages in a subsequent transaction (1) resulting in the Company’s shareholders having the right to exchange their shares for cash or other securities or (2) involving a consolidation, merger or other change in the majority of the Company’s board of directors or management team in which the company is the surviving entity.
The Initial Shareholders and holders of placement units will be entitled to registration rights pursuant to a registration rights agreement to be signed on or before the date of the prospectus for the Proposed Offering. The Initial Shareholders, including the Sponsor, will be entitled to demand registration rights and certain “piggy-back” registration rights with respect to their shares of common stock, and the Sponsor and Cantor Fitzgerald, as the holders of placement units, will be entitled to such rights with respect to their placement warrants and the common shares underlying the warrants, commencing on the date such common stock or warrants are released from the transfer restrictions set forth in the previous paragraph. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
5. COMMITMENTS & CONTINGENCIES
The Company expects to grant the underwriters a 45-day option to purchase up to 1,500,000 additional Units to cover the overallotments at the initial public offering price less the underwriting discounts and commissions.
The underwriters will be entitled to an underwriting discount of two percent (2.0%) of the gross proceeds of the Proposed Offering, excluding any amounts raised pursuant to the overallotment option. In addition, Cantor Fitzgerald will be entitled to a deferred fee of (i) five percent (5.0%) of the gross proceeds of the Proposed Offering, excluding any amounts raised pursuant to the overallotment option, and (ii) seven percent (7.0%) of the gross proceeds of any Units sold in the Proposed Offering pursuant to the overallotment option, payable in cash upon the closing of a Business Combination.
6. STOCKHOLDER’S EQUITY
Common Stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.001 per share. Holders of the Company’s common stock are entitled to one vote for each common share. At October 31, 2014, there were 3,916,667 common shares outstanding.
Preferred Stock — The Company is authorized to issue 5,000,000 shares of preferred stock with a par value of $0.001 per shares. At October 31, 2014, there were no preferred shares outstanding.
7. SUBSEQUENT EVENTS
On January 12, 2015, the Company issued 16,666 shares of common stock to the Sponsor for an aggregate purchase price of $250. These shares were issued in connection with the increased proposed sale of placement units from 250,000 to 300,000 placement units in order to maintain the ownership represented by the Founder Shares at 25% of the total shares outstanding following the Proposed Offering.
F-12
Table of Contents
$100,000,000
FinTech Acquisition Corp.
10,000,000 Units
Cantor Fitzgerald & Co.
Until March 9, 2015, all dealers that buy, sell or trade these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.